theravance inc (THRX:NASDAQ GS)
Rick E. Winningham
Chairman, Chief Executive Officer, Member of Stock Option Committee and Member of Science & Technology Advisory Committee, Theravance Inc.
|Age||Total Calculated Compensation||This person is connected to 69 board members in 5 different organizations across 5 different industries.|
See Board Relationships
As of Fiscal Year 2013
Mr. Rick E Winningham has been the Chief Executive Officer at Theravance Inc., since October 2001. Mr. Winningham served as President of Theravance Inc. since October 2001. Mr. Winningham held various management positions with Bristol-Myers Squibb and its predecessor, Bristol-Myers, since 1986. During his tenure with BMS, he was associated with the development and commercialization of several major pharmaceutical products, such as Taxol, Paraplatin, Zerit, Videx, Reyataz, ...
901 Gateway BoulevardPhone: 650-238-9600
South San Francisco, California 94080
Board Members Memberships*
Chairman, Chief Executive Officer, Member of Stock Option Committee and Member of Science & Technology Advisory Committee
Lead Independent Director, Member of Compensation Committee and Member of Nominating & Corporate Governance Committee
Texas Christian University
Southern Illinois University, Carbondale Campus
|Howard W. Robin||Chief Executive Officer, President and Director|
|Peter M. Hecht Ph.D.||Co-Founder, Chief Executive Officer and Director|
Ironwood Pharmaceuticals, Inc.
|Mark R. Baker J.D.||Chief Executive Officer, Director and Member of Science & Strategy Committee|
Progenics Pharmaceuticals, Inc.
|Peter S. Greenleaf||Chief Executive Officer, Director, Member of Commercialization Committee and Member of Science & Technology Committee|
Sucampo Pharmaceuticals, Inc.
|Richard Martin Steeves BSc., Ph.D.||Group Chief Executive Officer, Member of Senior Executive Board and Executive Director|
Synergy Health plc
|823.0K GBP||Compensation as of Fiscal Year 2013.|